A Cross-Sectional Analysis of Migraine-Related Disability in CADASIL: A Mayo Clinic Cohort.


Journal

The neurologist
ISSN: 2331-2637
Titre abrégé: Neurologist
Pays: United States
ID NLM: 9503763

Informations de publication

Date de publication:
Nov 2019
Historique:
entrez: 6 11 2019
pubmed: 7 11 2019
medline: 25 4 2020
Statut: ppublish

Résumé

Cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is inherited microangiopathy characterized by recurrent subcortical infarcts. A majority of those with CADASIL report coexistent migraine with aura. The authors aim to quantitatively describe migraine-related disability within a CADASIL cohort. A cross-sectional analysis was performed in a cohort of CADASIL. The Migraine Disability Assessment (MIDAS) quantified migraine-related disability. Further metrics obtained include first and last migraine, aura semiology, and therapeutic measures. Twenty-four individuals were included [63% (15/24) female individuals; mean age, 56 y; range, 34 to 81 y]. Fifty-four percent (13/24) reported migraine, whereas 46% (11/24) reporting varying degrees of migraine-related disability. MIDAS Questionnaire scores appeared bimodal: 58% (14/24) scored 0 to 5, 7% (1/24) scored 6 to 10, 7% (1/24) scored 11 to 20 and 33% (8/24) scored over 20. Severe disability was associated with the multiplicity of aura semiologies and poor response to pharmacologic prophylaxis. A bimodal distribution of migraine-related disability was observed. A third of individuals had a severe disability and appeared medically refractory to medical migraine prophylactic measures. This study may serve as a reference point for future trials quantitatively gauging response of novel migraine treatment strategies within this unique population.

Identifiants

pubmed: 31688705
doi: 10.1097/NRL.0000000000000253
pii: 00127893-201911000-00001
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

161-164

Auteurs

Eric D Goldstein (ED)

Department of Neurology, Mayo Clinic, Jacksonville, FL.

Mohammed K Badi (MK)

Department of Neurology, Mayo Clinic, Jacksonville, FL.

James P Klaas (JP)

Department of Neurology, Mayo Clinic, Rochester, MN.

Patrick Glover (P)

Department of Neurology, Mayo Clinic, Jacksonville, FL.

Todd D Rozen (TD)

Department of Neurology, Mayo Clinic, Jacksonville, FL.

Josephine F Huang (JF)

Department of Neurology, Mayo Clinic, Jacksonville, FL.

Michelle P Lin (MP)

Department of Neurology, Mayo Clinic, Jacksonville, FL.

James F Meschia (JF)

Department of Neurology, Mayo Clinic, Jacksonville, FL.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH